Appili Therapeutics (OTCMKTS:APLIF – Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.01) EPS for the quarter, hitting analysts’ consensus estimates of ($0.01), reports. The company had revenue of $0.01 million for the quarter.
Appili Therapeutics Stock Performance
APLIF opened at $0.03 on Thursday. Appili Therapeutics has a fifty-two week low of $0.02 and a fifty-two week high of $0.08. The company has a market capitalization of $3.13 million, a P/E ratio of -0.86 and a beta of -0.53. The stock has a fifty day moving average of $0.03 and a 200-day moving average of $0.03.
About Appili Therapeutics
Recommended Stories
- Five stocks we like better than Appili Therapeutics
- How to Calculate Inflation Rate
- Any Pullback in Tech May Signal a Rotation into These 3 Sectors
- What Does Downgrade Mean in Investing?
- 3 Stocks to Watch: Oracle, Casey’s, FedEx Signal Big Gains
- Energy and Oil Stocks Explained
- Stock Impact: McDonald’s Price War with Starbucks, Wendy’s
Receive News & Ratings for Appili Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Appili Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.